Azulfidine Générique est utilisé afin de traiter la colite ulcéreuse. On l'utilise également pour augmenter le délai entre les attaques de colite ulcéreuse.
In Early, Aggressive RA, Combo Initially Better Than MTX - Medscape
In Early, Aggressive RA, Combo Initially Better Than MTXMedscapeTwo-year data reported by the TEAR investigators online April 16 in Arthritis & Rheumatism indicate that the less expensive triple DMARD regimen (methotrexate [MTX]/sulfasalazine/hydroxychloroquine) is generally as effective as etanercept/MTX and that .
Pfizer's Arthritis Pill Gets Nod from FDA Panel - MedPage Today
Pfizer's Arthritis Pill Gets Nod from FDA PanelMedPage TodayEven some who voted in favor expressed concerns about the possibility that tofacitinib could be used after failure of a single drug such as sulfasalazine or hydroxychloroquine, suggesting that the indication be limited to use after failure of .
Takeda's vedolizumab meets primary endpoints in Ph III Crohn's disease study - The Pharma Letter
Takeda's vedolizumab meets primary endpoints in Ph III Crohn's disease studyThe Pharma LetterUlcerative colitis can be treated with a number of medications including aminosalicylates such as sulfasalazine, corticosteroids such as prednisone, immunosuppressive medications such as azathioprine, and biological agents such as infliximab, .
IL-17 Blocker Promising for Spondylitis - MedPage Today
IL-17 Blocker Promising for SpondylitisMedPage TodayThey were allowed to continue on stable doses of other medications such as methotrexate, sulfasalazine, and prednisone.
Arthritis Pill Gets Nod from FDA Panel - Everyday Health
Arthritis Pill Gets Nod from FDA PanelEveryday HealthEven some who voted in favor expressed concerns about the possibility that tofacitinib could be used after failure of a single drug such as sulfasalazine or hydroxychloroquine, suggesting that the indication be limited to use after failure of .